SFM
IMVT icon

Sphera Funds Management’s Immunovant IMVT Stock Holding History

Sphera Funds Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-256,743
Closed -$4.14M – 116
2025
Q3 		$4.14M Hold
256,743
– – 0.87% 40
2025
Q2 		$4.11M Buy
256,743
+62,105
+32% +$939K 0.96% 38
2025
Q1 		$3.33M Buy
+194,638
New +$4.07M 0.77% 42
2021
Q2 		– Sell
-158,500
Closed -$2.54M – 153
2021
Q1 		$2.54M Sell
158,500
-11,500
-7% -$303K 0.2% 101
2020
Q4 		$7.85M Hold
170,000
– – 0.7% 46
2020
Q3 		$5.98M Buy
170,000
+65,000
+62% +$1.95M 0.59% 49
2020
Q2 		$2.56M Buy
105,000
+85,968
+452% +$1.84M 0.24% 69
2020
Q1 		$296K Sell
19,032
-968
-5% -$14.6K 0.04% 74
2019
Q4 		$317K Buy
+20,000
New +$224K 0.03% 85

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Sphera Funds Management's IMVT Position: Q4 2025 in Review

Sphera Funds Management sold out of Immunovant (IMVT) in Q4 2025, closing a stake of 256,743 shares — an estimated $4.14M sold.

Sphera Funds Management first reported a position in IMVT in Q4 2019 and held it in 9 quarters. The position peaked at $7.85M in Q4 2020. 196 funds tracked by Wall St. Rank hold IMVT as of Q4 2025.

  • Sphera Funds Management reported no remaining Immunovant position as of Q4 2025 after selling out during the quarter.
  • Sphera Funds Management sold 256,743 Immunovant shares in Q4 2025, an estimated $4.14M.
  • Sphera Funds Management first reported a position in Immunovant in Q4 2019 and held it in 9 quarters.
  • Sphera Funds Management's Immunovant position peaked at $7.85M in Q4 2020.
  • 196 funds tracked by Wall St. Rank held Immunovant as of Q4 2025.

Based on Sphera Funds Management's 13F filing for Q4 2025, filed 17 Feb 2026.